Meditrina Pharmaceuticals repurposes therapies for women's health disorders, focusing on gynecologic conditions.
Meditrina Pharmaceuticals, Inc. was founded with a mission to improve women's health by repurposing already marketed therapies and advanced-stage product candidates for new indications. The company's vision is to address unmet medical needs in overlooked therapeutic areas affecting millions of women annually. Meditrina focuses on gynecologic and aromatase-mediated conditions such as endometriosis and uterine fibroids, aiming to provide effective treatments for these prevalent health issues.
The company has garnered attention for its innovative approach to drug repurposing, leveraging existing therapies to expedite the development process and reduce costs. Notable affiliated individuals and investors have supported Meditrina's mission, contributing to its growing reputation in the women's health sector. Through its targeted focus and strategic repurposing of therapies, Meditrina Pharmaceuticals has made significant strides in addressing critical health concerns for women, positioning itself as a key player in the industry.
Meditrina Pharmaceuticals' most recent funding round was for $50k (USD) in December 2010.
As of Dec 27, 2010, Meditrina Pharmaceuticals has disclosed funding of $4.5M (USD).

Meditrina

FemmePharma Global Healthcare
fpghc.com

VitaMedMD
vitamedmd.com

Estrigenix Therapeutics
estrigenix.com

Evestra
evestra.com
Metera Pharmaceuticals
Sojournix

Medison Pharma
medisonpharma.com

MenoGeniX
menogenix.com

Materna Medical
maternamedical.com
MidwayBiome
midwaypharma.com

Avana Health
avana.health

MediciNova
medicinova.com
Citrine Medicine

Madorra
madorra.com
Melior Pharmaceuticals

Essential Remedium

Hera Health Solutions